跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Gapenak 300 - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Gapenak 300
Approved
STANDARD
Gapenak 300
Hetero Labs Limited (Unit V)
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
7ee15274c701d88d
Company
Hetero Labs Limited (Unit V)
Type
Standard
Approval Details
Approval Id
7ee15274c701d88d
Drug Approval Philippines Name
Gapenak 300
Product Name
Gapenak 300
Registration Number
DRP-15037
Brand Name
Gapenak 300
Generic Name
Gabapentin
Dosage Form
Capsule
Dosage Strength
300 mg
Manufacturer
Hetero Labs Limited (Unit V)
Importer
Camber Pharmaceuticals, Inc.
Distributor
Camber Pharmaceuticals, Inc.
Importer Detail Path
/organization/camber-pharmaceuticals-inc
Distributor Detail Path
/organization/camber-pharmaceuticals-inc
Issuance Date
25 March 2024
Expiry Date
25 March 2029
Pharmacologic Category
Antiepileptic
Classification
Prescription (Rx) Drug
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
7ee15274c701d88d
Type
Standard
Back to Philippines FDA Approvals